WHO ICTRP trial
A Four-Part, Open Label, Randomized, Parallel Assignment Study to Evaluate the…
NL-OMON53403 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON53403 |
|---|---|
| Public title | A Four-Part, Open Label, Randomized, Parallel Assignment Study to Evaluate the Pharmacodynamics of Nirogacestat on B-Cell Maturation Antigen (BCMA) |
| Scientific title | A Four-Part, Open Label, Randomized, Parallel Assignment Study to Evaluate the Pharmacodynamics of Nirogacestat on B-Cell Maturation Antigen (BCMA) - Phase I pharmacodynamic, pharmacokinetics study of Nirogacestat on BCMA |
| Primary sponsor | SpringWorks Therapeutics, Inc. |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | multiple myeloma multiple myeloma;10018865;multiple myeloma |
| Interventions | Part 1 During Part 1 of the study, no study compound will be given. Part 2 Subjects will receive a single oral dose with 150 mg nirogacestat (3 tablets of 50 mg each) on Day 1. Part 3 The dose and the number of doses subjects will receive… |
| Registration date | Mar 27, 2023 |
| Target size | 27 |
| Secondary IDs | 2022-000386-40;NL80762.056.22 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: